Although TPO-RA drugs have not been approved by any regulatory agency for use in pregnancy, there are some retrospective studies and case reports focus on the use of TPO-RA in pregnant women with ITP (20, 22). Here, TPO is linked to autoimmune thrombocytopenic purpura.